Home » Topics » BioWorld Science

BioWorld Science
RSS

Cephalon research reveals active compounds

June 14, 1996

RPR's riluzole approved in Europe

June 14, 1996

Myotrophin still pending full marketing approval

June 14, 1996

Xytronyx and Binary Therapeutics enter acquisition agreement

June 14, 1996

Medeva acquires Rochester business pipeline from RPR

June 14, 1996

Ascalon: Titan's newly formed subsidiary

June 14, 1996

Lilly/Merck-Medco Managed Care diabetes program development agreement

June 14, 1996

HemaSure/American Red Cross Biomedical Services alliance

June 14, 1996

Exelixis acquires rights to P Element technology

June 14, 1996

Bayer/CV Therapeutics antiinflammatory drug agreement

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery
BioWorld Science
Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...